FDA Approves Opdivo, Yervoy Drug Combo To Treat Mesothelioma
The FDA has approved the use of a drug combination of Opdivo and Yervoy as a first-line treatment for mesothelioma.
Tag Archives: Yervoy
-
-
Yervoy, Keytruda Linked To Muscoskeletal Immune-Related Adverse Event Problems: Study
The side effects of Yervoy, Keytruda and other similar cancer drugs may increase the risk of musculoskeletal problems, according to the findings of a new study.
-
Opdivo/Yervoy Drug Combo Toxic For Most Cancer Patients: Study
A new study warns that combination cancer therapy involving Opdivo and Yervoy may often be too toxic for patients, resulting in hospitalizations and emergency room visits due to immune system…
-
Opdivo, Yervoy Treatments May Slow Mesothelioma Progression: Study
The cancer drugs Opdivo and Yervoy may slow the progression of mesothelioma, according to the findings of a new study.
-
Side Effects of Opdivo and Yervoy May Be Linked To Fatal Heart Risk: Study
Two Bristol-Myers Squibb cancer drugs, Opdivo and Yervoy, may be linked to fatal heart problems when used in combination, according to the findings of a new study.
-
Cancer Drugs Yervoy and Opdivo May Increase Risk of Arthritis: Study
The cancer drugs Yervoy and Opdivo could increase the risk of arthritis, according to the findings of a new case study.
